Aduro Biotech
ADRO
#8332
Rank
HK$1.84 B
Marketcap
HK$114.05
Share price
4.18%
Change (1 day)
N/A
Change (1 year)

Revenue for Aduro Biotech (ADRO)

Revenue in 2020 (TTM): HK$0.21 Billion

According to Aduro Biotech's latest financial reports the company's current revenue is HK$0.21 Billion. In 2019 the company made a revenue of HK$0.13 Billion an increase over the revenue in the year 2018 that were of HK$0.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aduro Biotech from 2014 to 2020

Annual revenue

Year Revenue Change
2020 (TTM)HK$0.21 B61.15%
2019HK$0.13 B14.39%
2018HK$0.11 B-12.48%
2017HK$0.13 B-65.99%
2016HK$0.39 B-30.55%
2015HK$0.57 B445.07%
2014HK$0.10 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Sarepta Therapeutics
SRPT
HK$18.85 B 8,533.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$5.52 B 2,432.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
HK$0.65 B 198.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
HK$7.51 M-96.56%๐Ÿ‡ฉ๐Ÿ‡ช Germany